Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Tamoxifen caused hair loss in a 52-year-old woman.

Platelet-rich treatments can help improve wound healing and tissue repair.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Testosterone may both worsen and protect against COVID-19 effects in men.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

PCOS treatment should be personalized, using birth control pills or metformin for symptoms, with lifestyle changes being essential.

Possible link between androgens and COVID-19 severity; more research needed.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.